Ionis Pharmaceuticals's total assets for Q4 2023 were $2.99B, an increase of 1.91% from the previous quarter. IONS total liabilities were $2.60B for the fiscal quarter, a -0.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.